To compare the efficacy of emollient versus topical luliconazole (azole) in the maintenance of remission of recurrent dermatophytosis after adequate systemic treatment.

A randomized study to evaluate and compare the efficacy of emollient versus topical luliconazole in the maintenance of remission of recurrent dermatophytosis after adequate systemic treatment.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/049161

Enrollment

Registered

2023-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Tab/ Capsule Itraconazole Topical Luliconazole Cream Tab L

evocetrizine: Patients above 18 years of age with tinea infection of more than 6 months involving groins, glabrous skin fulfilling inclusion criteria will be included and will be randomized to two gro

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and females >18 years of age. 2. Patients having tinea infection for more than 6 months. 3. Providing signed consent forms after understanding the written contents outlining the requirements of participating in the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding woman. 2. Patients suffering from diseases where immunosuppressants are indicated like autoimmune conditions. 3. Patients with history of heart disease especially chronic heart failure 4. Patients with concomitant other skin diseases. 5. Patients with tinea capitis. 6. Patients with abnormal liver function test

Design outcomes

Primary

Measure	Time frame
1.To assess the efficacy of emollient in the remission maintenance of recurrent dermatophytosis.(Using Physician Global Assessment score and Patient Global Assessment of Disease Status) 2.To compare the efficacy of emollient with topical luliconazole use in the remission of tinea infection. We tend to monitor remission of disease in the form of new tinea lesions through the validated scores.Timepoint: 6 weeks The assessment of data in the follow up period will be assessed with the validated scoring system both for the physician and patient. Data collected will be statistically assessed using independent â??Tâ?? test.	—

Measure

Time frame

1.To assess the efficacy of emollient in the remission maintenance of recurrent dermatophytosis.(Using Physician Global Assessment score and Patient Global Assessment of Disease Status) 2.To compare the efficacy of emollient with topical luliconazole use in the remission of tinea infection. We tend to monitor remission of disease in the form of new tinea lesions through the validated scores.Timepoint: 6 weeks The assessment of data in the follow up period will be assessed with the validated scoring system both for the physician and patient. Data collected will be statistically assessed using independent â??Tâ?? test.

—

Secondary

Measure	Time frame
To evaluate the effectiveness of extended use of topical luliconazole for maintenance of remission in recurrent dermatophytosis patients. We tend to monitor remission of disease in the form of new tinea lesions through the validated scores. Timepoint: 18 weeks	—

Countries

India

Contacts

Public ContactDr Yashdeep Singh Pathania

AIIMS Rajkot

yashdeepsinghpathania@gmail.com8894480089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026